Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Bioprocess Technology Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The bioprocess technology market size has experienced swift growth in recent years. It is anticipated to expand from $28.71 billion in 2025 to $33.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.5%. This historical market expansion can be attributed to several factors, including the broadening of biopharmaceutical manufacturing, the increasing application of cell-based therapies, the proliferation of research and development activities, a heightened demand for biologics, and the presence of advanced laboratory infrastructure.
The bioprocess technology market size is anticipated to expand rapidly over the coming years. This market is projected to reach $59.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.5%. Driving this expansion throughout the forecast period are several factors, including heightened investments in biologics and biosimilars, a greater uptake of continuous bioprocessing methods, the broadening scope of personalized medicine production, an intensifying emphasis on sustainable biomanufacturing practices, and the progressive incorporation of digital process control systems. Key developments anticipated during this period encompass the wider acceptance of single-use bioprocessing systems, an increasing need for scalable cell culture technologies, the growing integration of automation within bioreactors, the advancement of sophisticated cell line development techniques, and a sharpened focus on optimizing processes and improving yield efficiency.
Get A Free Sample Report With In-Depth Market Insights:
Bioprocess Technology Market Growth Drivers: What’s Behind The Acceleration?
The escalating occurrence of chronic illnesses is anticipated to fuel the expansion of the bioprocess technology market. A chronic disease is defined as a condition persisting for at least three months, with the potential to worsen over time. Bioprocess technology plays a crucial role in developing and manufacturing gene therapies, vaccines, cell cultures, fermentation products, and monoclonal antibodies, which are vital for addressing chronic diseases, thereby advancing medical science and enhancing patient quality of life. As an illustration, data from January 2023, reported by the US-based National Library of Medicine, projects a 99.5% rise in the number of individuals aged 50 and older in the US with at least one chronic ailment, reaching 142.66 million by 2050. Consequently, the rising incidence of chronic diseases is a key factor boosting the bioprocess technology market’s growth.
Bioprocess Technology Market Segmentation And Category Overview
The bioprocess technology market covered in this report is segmented –
1) By Type: Cell Culture, Cell Expansion, Flow Cytometry, Cell Line Development, Virus Filtration
2) By Application: Biopharmaceuticals, Specialty Products, Industry Chemicals, Environment Management Aid
3) By End User: Hospitals, Research labs, Medical Institutions, Other End Users
Subsegments:
1) By Cell Culture: Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture
2) By Cell Expansion: Adherent Cell Expansion, Suspension Cell Expansion
3) By Flow Cytometry: Cell Analysis, Cell Sorting
4) By Cell Line Development: Hybridoma Technology, Recombinant Cell Line Development
5) By Virus Filtration: Viral Vector Production, Virus Filtration Techniques
Bioprocess Technology Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies within the bioprocess technology market are developing innovative service options, such as the custom organoid line expansion service, to secure a competitive advantage. This custom organoid line expansion service utilizes proprietary bioreactor and bioprocess technology to facilitate the scaled-up production of organoids. For example, in July 2023, Molecular Devices LLC, a US-based Research and development company, introduced its custom organoid line expansion service. This service assists researchers by enabling the parallel screening of thousands to tens of thousands of drug candidates on organoids originating from a consistent source. It is designed to bolster next-generation drug discovery research and permits the creation of patient-derived organoids (PDOs) that are more efficient, reproducible, and scalable.
Bioprocess Technology Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the bioprocess technology market are Sartorius AG; Thermo Fisher Scientific Inc.; Lonza Group AG; F. Hoffmann-La Roche Ltd.; Becton Dickinson and Company; Merck KGa; GE Healthcare; Eppendorf AG; Bio-Rad Laboratories; Catalent Inc.; Advanced Instruments LLC; MilliporeSigma; Repligen Corporation; Danaher Corporation; PerkinElmer Inc.; Applikon Biotechnology; New Brunswick Scientific Co. Inc.; Avid Bioservices; Meissner Filtration Products; 3M; Eppendorf Biochip Systems; Fermenter Bioreactor; Solaris Biotechnology Srl; Aber Instruments; Cytiva
View The Full Bioprocess Technology Market Report:
Bioprocess Technology Market Regional Analysis And Top Geography
North America was the largest region in the bioprocess technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioprocess technology market report during the forecast period. The regions covered in the bioprocess technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
